Status:
UNKNOWN
Augmented Reality for Subdural Drain Placement
Lead Sponsor:
Stanford University
Conditions:
Subdural Hematoma
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study involves using a augmented reality (AR) system to assist in the placement of a subdural evacuating portal system (SEPS). In the first part of the study, all participants will have skin mark...
Detailed Description
Chronic/subacute subdural hematoma (SDH) is one of the most common diseases encountered in neurosurgical practice. However, there is little consensus on first-line treatment. The SEPS was developed to...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Unilateral or Bilateral subdural hematoma that is planned to be treated by SEPS
- Exclusion Criteria
- Unable to have CT scan
- Pregnancy
Exclusion
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06052124
Start Date
November 1 2023
End Date
December 1 2025
Last Update
September 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University Hospital
Stanford, California, United States, 94305